Evidence map›Paper›PMID 36851086›Full record

ArticleVaccines2023

A Comparison of Strategies to Improve Uptake of COVID-19 Vaccine among High-Risk Adults in Nairobi, Kenya in 2022.

Joan Yego, Robert Korom, Emma Eriksson, Sharon Njavika, Oulimata Sane, Purity Kanorio, Oliver Rotich, Stellah Wambui, Eunice Mureithi

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Joan YegoPenda Health Ltd., Nairobi P.O. Box 22647-00100, Kenya.
Robert KoromPenda Health Ltd., Nairobi P.O. Box 22647-00100, Kenya.ORCID 0000-0003-1567-4991
Emma ErikssonDalberg Advisors, Nairobi P.O. Box 100657-00100, Kenya.
Sharon NjavikaDalberg Advisors, Nairobi P.O. Box 100657-00100, Kenya.
Oulimata SaneDalberg Advisors, Nairobi P.O. Box 100657-00100, Kenya.
Purity KanorioPenda Health Ltd., Nairobi P.O. Box 22647-00100, Kenya.
Oliver RotichPenda Health Ltd., Nairobi P.O. Box 22647-00100, Kenya.
Stellah WambuiPenda Health Ltd., Nairobi P.O. Box 22647-00100, Kenya.
Eunice MureithiPenda Health Ltd., Nairobi P.O. Box 22647-00100, Kenya.
Penda Health · KE

Funding

Dalberg Catalyst a 501(c)(3) public charity, 1401 K Street NW, #900 Washington DC 20005N N/A
6 · The paper itself

Abstract

backgroundCOVID-19 vaccine uptake in Kenya is still low compared to other countries, especially in Europe and North America. In most parts of the country, a large percentage of the Kenyan population remains unvaccinated. As of October 2022, the Ministry of Health (Kenya) estimates that only 36.2% of the adult population had been fully vaccinated.

methodsWe conducted an experimental study in April 2022 targeting unvaccinated adults who had a history of hypertension and/or diabetes and those in the 60+ age group. We tested various messaging approaches using two different intervention channels.

resultsAlthough the overall rate of vaccinated individuals according to national records is low, responses from the study group collected through phone call conversations show that higher-risk adults such as those older than 60 or those with chronic illnesses have a remarkably high vaccination rate of 89%. After the study, four participants received a COVID-19 vaccine within 1 month of the intervention. These four participants all received a loss-messaging intervention approach during the study.

conclusionThis study supports a national approach to increasing COVID-19 vaccination rates using loss-messaging directed at unvaccinated, high-risk individuals.

Indexed as

COVID-19high-risk groupsKenyavaccine uptake interventions

Identifiers

PMID36851086
PMCPMC9965704
OpenAlexW4317393631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.